Muscle & Growth Hormone

Sermorelin

GHRH(1-29) · GRF 1-29

FDA-approvedpopularsubQ injection

What it is

Sermorelin is a 29-amino-acid synthetic version of the active region of natural GHRH (growth hormone-releasing hormone). It was the first GHRH analog approved by the FDA — originally for pediatric growth hormone deficiency. Today it's the most widely prescribed GH-secretagogue for adult anti-aging and body composition use, prized for its mild side-effect profile and gradual, physiological GH response.

How it works

Sermorelin tells your pituitary gland to release your own growth hormone in natural pulses, primarily during deep sleep. Unlike injecting synthetic HGH, you can't suppress endogenous production because the natural feedback loop stays intact. The effect is gentle and accumulates over months rather than days.

Benefits

Improved sleep depth and quality (typically the first effect)
Better recovery from training
Gradual fat loss, especially abdominal
Modest lean muscle gain over months
Improved skin quality and elasticity
Higher energy and mood lift in many users
Bone mineral density support over long-term use

Timeline

Week 1–2: Improved sleep quality — usually the first noticeable change.
Week 4: Better recovery, more energy.
Week 8–12: Visible body composition shifts; skin starts looking better.
Month 6+: Peak benefits — this is a long-game peptide.

Dosing & titration

Standard dose200–300 mcg subQ before bed

Optional split200 mcg AM + 200 mcg PM (more aggressive)

Cycle length3–6 months on, 1 month off to maintain receptor sensitivity

TimingOn empty stomach — aligns with natural pre-sleep GH pulse

When to titrate upIf 200 mcg produces no sleep improvement after 4 weeks, increase to 300 mcg or add a morning dose. Often paired with Ipamorelin for stronger combined GH pulse.

Side effects & risks

Mild flushing or warmth right after injection
Transient injection-site irritation
Headache (uncommon)
Mild water retention at higher doses
Drowsiness when dosed pre-bed (often desired)

Get baseline IGF-1 before starting and re-check at 12 weeks. Contraindicated in active malignancy and severe diabetic retinopathy.

Typical price

$80–$150/mo15 mg vial from a 503A compounding pharmacy. Often blended with Ipamorelin or GHRP-2.

Studies

Walker RF. Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? — Foundational review of clinical use in adults. PubMedClinical Interventions in Aging, 2006
Search PubMed for Sermorelin clinical studies — PubMed searchLive PubMed search
FDA approval history (Geref) — Original pediatric approval in 1990 for growth hormone deficiency.FDA Drugs@FDA

Educational reference only. Not medical advice.